Perimeter Ev To Sales vs Days Sales Outstanding Analysis

PINK Stock

CAD 0.49 0.01 2.00%

Perimeter Medical financial indicator trend analysis is much more than just breaking down Perimeter Medical Imaging prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Perimeter Medical Imaging is a good investment. Please check the relationship between Perimeter Medical Ev To Sales and its Days Sales Outstanding accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Perimeter Medical Imaging. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Ev To Sales vs Days Sales Outstanding

Ev To Sales vs Days Sales Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Perimeter Medical Imaging Ev To Sales account and Days Sales Outstanding. At this time, the significance of the direction appears to have strong relationship.

The correlation between Perimeter Medical's Ev To Sales and Days Sales Outstanding is 0.71. Overlapping area represents the amount of variation of Ev To Sales that can explain the historical movement of Days Sales Outstanding in the same time period over historical financial statements of Perimeter Medical Imaging, assuming nothing else is changed. The correlation between historical values of Perimeter Medical's Ev To Sales and Days Sales Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Sales of Perimeter Medical Imaging are associated (or correlated) with its Days Sales Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Sales Outstanding has no effect on the direction of Ev To Sales i.e., Perimeter Medical's Ev To Sales and Days Sales Outstanding go up and down completely randomly.

Correlation Coefficient

0.71

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Days Sales Outstanding

Most indicators from Perimeter Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Perimeter Medical Imaging current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Perimeter Medical Imaging. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Selling General Administrative is likely to drop to about 5.7 M in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year

	2021	2023	2024 (projected)
Depreciation And Amortization	93.8K	829.7K	871.1K
Interest Income	7.8K	9.0K	7.1K

Depreciation And Amortization Interest Income

Perimeter Medical fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab
Other Current Liab		-0.2	-0.48	0.49	-0.61	0.6	0.85	0.85	0.72	0.51	0.85	-0.49	0.67	0.82	-0.52	-0.72	0.86	0.82	-0.88	0.83	0.77	-0.65	0.83	0.58	0.3	-0.29
Total Current Liabilities	-0.2		0.75	-0.94	0.71	-0.63	-0.44	-0.65	-0.78	-0.8	-0.67	0.94	-0.85	-0.64	-0.31	0.8	-0.62	-0.64	0.4	-0.65	-0.75	0.3	-0.71	-0.86	-0.92	0.98
Other Liab	-0.48	0.75		-0.86	0.85	-0.94	-0.66	-0.74	-0.86	-0.97	-0.77	0.89	-0.86	-0.75	-0.07	0.85	-0.73	-0.75	0.6	-0.75	-0.83	0.49	-0.8	-0.86	-0.85	0.86
Net Tangible Assets	0.49	-0.94	-0.86		-0.88	0.77	0.66	0.83	0.92	0.89	0.86	-1.0	0.96	0.82	0.09	-0.94	0.81	0.82	-0.66	0.83	0.91	-0.51	0.88	0.95	0.93	-0.97
Retained Earnings	-0.61	0.71	0.85	-0.88		-0.81	-0.85	-0.75	-0.92	-0.84	-0.81	0.87	-0.85	-0.89	0.26	0.85	-0.74	-0.89	0.83	-0.75	-0.91	0.82	-0.87	-0.93	-0.88	0.79
Accounts Payable	0.6	-0.63	-0.94	0.77	-0.81		0.72	0.74	0.84	0.92	0.77	-0.81	0.82	0.83	-0.2	-0.8	0.73	0.83	-0.72	0.73	0.85	-0.56	0.84	0.85	0.7	-0.75
Net Receivables	0.85	-0.44	-0.66	0.66	-0.85	0.72		0.79	0.89	0.72	0.82	-0.65	0.75	0.94	-0.48	-0.75	0.77	0.94	-0.88	0.75	0.88	-0.92	0.88	0.82	0.63	-0.51
Total Current Assets	0.85	-0.65	-0.74	0.83	-0.75	0.74	0.79		0.9	0.8	1.0	-0.83	0.95	0.87	-0.07	-0.96	1.0	0.87	-0.78	1.0	0.92	-0.52	0.95	0.81	0.66	-0.7
Common Stock	0.72	-0.78	-0.86	0.92	-0.92	0.84	0.89	0.9		0.92	0.93	-0.92	0.96	0.96	-0.14	-0.93	0.88	0.96	-0.8	0.88	0.98	-0.73	0.97	0.97	0.87	-0.84
Property Plant Equipment	0.51	-0.8	-0.97	0.89	-0.84	0.92	0.72	0.8	0.92		0.82	-0.92	0.91	0.81	0.1	-0.87	0.77	0.81	-0.59	0.79	0.88	-0.52	0.85	0.91	0.88	-0.89
Total Assets	0.85	-0.67	-0.77	0.86	-0.81	0.77	0.82	1.0	0.93	0.82		-0.86	0.96	0.9	-0.13	-0.97	0.99	0.9	-0.82	0.99	0.95	-0.58	0.97	0.85	0.7	-0.73
Short Long Term Debt Total	-0.49	0.94	0.89	-1.0	0.87	-0.81	-0.65	-0.83	-0.92	-0.92	-0.86		-0.97	-0.82	-0.11	0.95	-0.82	-0.82	0.65	-0.84	-0.91	0.49	-0.88	-0.95	-0.93	0.98
Total Stockholder Equity	0.67	-0.85	-0.86	0.96	-0.85	0.82	0.75	0.95	0.96	0.91	0.96	-0.97		0.88	0.03	-0.99	0.93	0.88	-0.73	0.94	0.96	-0.52	0.95	0.93	0.85	-0.89
Property Plant And Equipment Net	0.82	-0.64	-0.75	0.82	-0.89	0.83	0.94	0.87	0.96	0.81	0.9	-0.82	0.88		-0.41	-0.87	0.85	1.0	-0.91	0.84	0.98	-0.82	0.98	0.93	0.73	-0.7
Current Deferred Revenue	-0.52	-0.31	-0.07	0.09	0.26	-0.2	-0.48	-0.07	-0.14	0.1	-0.13	-0.11	0.03	-0.41		0.02	-0.09	-0.41	0.64	-0.05	-0.23	0.64	-0.26	-0.13	0.17	-0.25
Net Debt	-0.72	0.8	0.85	-0.94	0.85	-0.8	-0.75	-0.96	-0.93	-0.87	-0.97	0.95	-0.99	-0.87	0.02		-0.96	-0.87	0.77	-0.97	-0.95	0.53	-0.95	-0.9	-0.81	0.85
Cash	0.86	-0.62	-0.73	0.81	-0.74	0.73	0.77	1.0	0.88	0.77	0.99	-0.82	0.93	0.85	-0.09	-0.96		0.85	-0.79	1.0	0.91	-0.5	0.94	0.78	0.63	-0.68
Non Current Assets Total	0.82	-0.64	-0.75	0.82	-0.89	0.83	0.94	0.87	0.96	0.81	0.9	-0.82	0.88	1.0	-0.41	-0.87	0.85		-0.91	0.84	0.98	-0.82	0.98	0.93	0.73	-0.7
Long Term Debt	-0.88	0.4	0.6	-0.66	0.83	-0.72	-0.88	-0.78	-0.8	-0.59	-0.82	0.65	-0.73	-0.91	0.64	0.77	-0.79	-0.91		-0.77	-0.87	0.83	-0.88	-0.76	-0.51	0.49
Cash And Short Term Investments	0.83	-0.65	-0.75	0.83	-0.75	0.73	0.75	1.0	0.88	0.79	0.99	-0.84	0.94	0.84	-0.05	-0.97	1.0	0.84	-0.77		0.91	-0.48	0.93	0.79	0.66	-0.71
Common Stock Shares Outstanding	0.77	-0.75	-0.83	0.91	-0.91	0.85	0.88	0.92	0.98	0.88	0.95	-0.91	0.96	0.98	-0.23	-0.95	0.91	0.98	-0.87	0.91		-0.72	0.99	0.96	0.81	-0.81
Non Current Liabilities Total	-0.65	0.3	0.49	-0.51	0.82	-0.56	-0.92	-0.52	-0.73	-0.52	-0.58	0.49	-0.52	-0.82	0.64	0.53	-0.5	-0.82	0.83	-0.48	-0.72		-0.7	-0.71	-0.56	0.37
Capital Lease Obligations	0.83	-0.71	-0.8	0.88	-0.87	0.84	0.88	0.95	0.97	0.85	0.97	-0.88	0.95	0.98	-0.26	-0.95	0.94	0.98	-0.88	0.93	0.99	-0.7		0.93	0.75	-0.77
Other Current Assets	0.58	-0.86	-0.86	0.95	-0.93	0.85	0.82	0.81	0.97	0.91	0.85	-0.95	0.93	0.93	-0.13	-0.9	0.78	0.93	-0.76	0.79	0.96	-0.71	0.93		0.92	-0.9
Other Stockholder Equity	0.3	-0.92	-0.85	0.93	-0.88	0.7	0.63	0.66	0.87	0.88	0.7	-0.93	0.85	0.73	0.17	-0.81	0.63	0.73	-0.51	0.66	0.81	-0.56	0.75	0.92		-0.94
Total Liab	-0.29	0.98	0.86	-0.97	0.79	-0.75	-0.51	-0.7	-0.84	-0.89	-0.73	0.98	-0.89	-0.7	-0.25	0.85	-0.68	-0.7	0.49	-0.71	-0.81	0.37	-0.77	-0.9	-0.94

Click cells to compare fundamentals

Perimeter Medical Account Relationship Matchups

Perimeter Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	2.4M	1.2M	1.9M	5.4M	4.6M	3.2M
Total Current Liabilities	18.5M	1.8M	2.1M	8.0M	6.9M	7.0M
Retained Earnings	(39.4M)	(47.3M)	(64.0M)	(59.3M)	(96.7M)	(91.9M)
Net Receivables	1.0M	604.3K	1.3M	2.0M	3.1M	1.6M
Total Current Assets	2.5M	13.1M	7.7M	31.5M	23.2M	14.8M
Common Stock	17.8M	48.5M	62.5M	80.8M	107.9M	60.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Perimeter Stock Analysis

When running Perimeter Medical's price analysis, check to measure Perimeter Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perimeter Medical is operating at the current time. Most of Perimeter Medical's value examination focuses on studying past and present price action to predict the probability of Perimeter Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perimeter Medical's price. Additionally, you may evaluate how the addition of Perimeter Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC